Skip to content

Clinical trials

Terminated Hypercholesterolemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Status: Terminated Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20052
20065
20079
20085
20093
20104
20116
20123
20131
20141
20153
20163
20175
20182
20192
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated61

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
Takeda5
Sanofi4
Amgen3
Organon and Co3
Pfizer3
Bristol-Myers Squibb2
Eli Lilly and Company2
Arbutus Biopharma Corporation1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia61
Hyperlipidemias11
Atherosclerosis8
Dyslipidemias8
Hypertension7
Obesity6
Cardiovascular Diseases5
Diabetes Mellitus5
Coronary Artery Disease4
Metabolic Syndrome3

Trials

Showing 26 to 50 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.